First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine

• Type of Material: Article
• Authors: J.D. Fuchs, San Francisco Departement of Public Health; I. Frank, University of Pennsylvania; N. Kochar, Fred Hutchinson Cancer Center; M. Elizaga, Fred Hutchinson Cancer Center; M. Allen, NIH; D. Carter, Fred Hutchinson Cancer Center; N. Frahm, Fred Hutchinson Cancer Center; S.A. Kalams, Vanderbilt University; Mark Mulligan, Emory University; R. Sheets, NIH; M. Pensiero, NIH; D. Clarke, Profectus Biosciences; J. Eldridge, Profectus Biosciences
• Language: English
• Date: 2012-09-13
• Publisher: BioMed Central
• Publication Version: Final Published Version
• Copyright Statement: ©2012 Fuchs et al
• License: Creative Commons Attribution 2.0 Generic
• Final Published Version (URL): http://dx.doi.org/10.1186/1742-4690-9-S2-P134
• Title of Journal or Parent Work: Retrovirology
• ISSN: 1742-4690
• Volume: 9
• Issue: Suppl 2
• Start Page: P134
• End Page: P134
• Keywords: Science & Technology; Virology; VIROLOGY; Life Sciences & Biomedicine
• Research Categories: Health Sciences, Public Health; Health Sciences, Oncology